Coronally advanced flap combined with Geistlich Mucograft for the treatment of recession type defects: a randomized controlled clinical trial. - A prospective study on the Geistlich Mucograft collagen matrix.

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 40 人开始时间: 待定最近更新: 2024年4月29日

适应症

试验速览

暂无简介。

•1. Patients have to present in good general health
•2. Only non-smokers will be included
•3. Good oral hygiene, i.e. full-mouth plaque score (FMPS) < 20%
•4. Low levels of residual periodontal infection, i.e. full-mouth bleeding score (FMBS) < 20%
•5. Only patients with optimal compliance will be enrolled in the study
•6. Patients have to be willing to adhere to a strict Supportive Periodontal Therapy (SPT) protocol
•7. Patients must be candidate for recession coverage presenting at least one, maximum 5 maxillary Miller class I or II recession type defect(s)

•1. Patients not fulfilling the inclusion criteria
•2. Patient with uncontrolled or poorly controlled diabetes, using anticoagulants, presenting unstable or life-threatening conditions, or requiring antibiotic prophylaxis wil be exluded

发起方

niversitair Medisch Centrum Sint Radboud